CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV
Chia-Chen Lin
◽
Shih-Huan Su
◽
Wen-Juei Jeng
◽
Chien-Hao Huang
◽
Wei Teng
◽
...
A Staettermayer
◽
K Rutter
◽
S Beinhardt
◽
TM Scherzer
◽
K Zinober
◽
...
2013 ◽
Vol 59
(5)
◽
pp. 957-963
◽
Hwalih Han
◽
Mazen Noureddin
◽
Michael Witthaus
◽
Yoon J. Park
◽
Jay H. Hoofnagle
◽
...
2011 ◽
Vol 54
◽
pp. S525
◽
Y. Karino
◽
I. Ozeki
◽
J. Toyota
◽
M. Imamura
◽
M. Tsuge
◽
...
2013 ◽
Vol 209
(10)
◽
pp. 1591-1601
◽
Qinglai Meng
◽
M. R. Sandhya Rani
◽
Julia M. Sugalski
◽
Chelsey J. Judge
◽
Sarah Phat
◽
...
2011 ◽
Vol 6
(7)
◽
pp. e20904
◽
Thomas R. O'Brien
◽
James E. Everhart
◽
Timothy R. Morgan
◽
Anna S. Lok
◽
Raymond T. Chung
◽
...
2016 ◽
Vol 59
(2)
◽
pp. 67-68
◽
Lucio Boglione
◽
Jessica Cusato
◽
Giovanni Di Perri
◽
Antonio D'Avolio
2019 ◽
Vol 60
(6)
◽
pp. 323-323
◽
2017 ◽
Vol 66
(1)
◽
pp. S281-S282
P. Ponzo
◽
G. Troshina
◽
A. Tucci
◽
L. Venezia
◽
M. Sacco
◽
...
2014 ◽
Vol 60
(1)
◽
pp. S473
A. Mangia
◽
V. De Ledinghen
◽
F. Bailly
◽
J. Brahm
◽
J. Keiss
◽
...